High-throughout transriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer

: Paula Vainio, John-Patrick Mpindi, Pekka Korhonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin

: 2012

: PLoS ONE

: 6

: 7

: 6

: e3981

: 13

: 1932-6203

DOI: https://doi.org/10.1371/journal.pone.0039801(external)